Closed consultation

Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

The MHRA is seeking views on the reclassification from pharmacy to general sale list of Nurofen Express 400mg Oral Powder.

This consultation ran from
to

Consultation description

This consultation seeks your views on the reclassification from pharmacy (P) to general sale list (GSL) of Nurofen Express 400mg Oral Powder.

You are invited to comment on the proposal, a copy of which can be found above. A form for your reply is also attached.

Comments should be sent to Abiodun Aderogba at the MHRA Reclassification Unit.

Documents

Change in classification of Nurofen Express 400mg Oral Powder (ARM 86)

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 6 January 2014